期刊文献+

原发性肝癌术后早期复发的危险因素分析 被引量:5

Risk factors of early recurrence of tumor after hepalobectomy in patients with primary liver cancer
暂未订购
导出
摘要 目的:探讨原发性肝癌(PLC)患者术后早期复发的危险因素。方法在51例 PLC 患者,选取17项临床和组织病理学参数,分析 PLC 术后早期复发的相关因素。结果发现血清 AST 水平(P〈0.001)、是否伴有肝硬化(P〈0.001)、肿瘤包膜是否完整(P=0.003)和血管侵犯(P=0.006)与早期复发相关;通过 Kaplan-Meier 法和 Cox 风险比例模型筛选发现有肝硬化(风险比=2.865,95%可信区间为1.846~8.466,P〈0.001)、肿瘤包膜缺失(风险比=3.357,95%可信区间为1.526~6.949,P=0.002)和血管侵犯(风险比=2.230,95%可信区间为1.094~4.548,P=0.027)是 PLC 术后早期复发的独立危险因素。结论对于有肝硬化、肿瘤包膜缺失和伴有血管侵犯等危险因素的 PLC 患者,术后应加强随访,以期及早发现肿瘤复发并给予及时的治疗。
出处 《实用肝脏病杂志》 CAS 2014年第2期194-195,共2页 Journal of Practical Hepatology
关键词 原发性肝癌 早期复发 危险因素 Primary liver cancer Hepalobectomy Recurrence Risk factors
  • 相关文献

参考文献10

  • 1Hoshida Y,Villanueva A,Kobayashi M,et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med,2008,359:1995-2004.
  • 2Portolani N,Coniglio A,Ghidoni S,et al. Early and late recur- rence after liver resection for hepatocellular tic and therapeutic implications. Ann Surg,2006,243:229-235.
  • 3Takayarna T,Sekine T,Makuuchi M,et al. Adoptive immunother- apy to lower postsurgieal recurrence rates of hepatoeellular ear- einoma:a randomised trial. Lancet,2000,356:802-807.
  • 4Poon RT,Fan ST,Ng IO, et al. Different risk factors and prog- nosis for early and late intrahepatie recurrence after resection of hepatocellular carcinoma. Cancer,2000,89:500-507.
  • 5高明,龚瑾,曹明溶,劳学军.原发性肝癌术后早期复发的相关因素[J].广州医学院学报,2011,39(2):86-88. 被引量:3
  • 6Chen PJ,Chen DS,Lai MY,et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology, 1989,96:527-529.
  • 7欧迪鹏,杨连粤,黄耿文,陶一明,丁翔,常志刚.肝细胞癌术后复发转移相关危险因素分析[J].中南大学学报(医学版),2005,30(5):540-543. 被引量:6
  • 8潘金强,段永亮,肖红.小肝癌患者术后肝内早期复发的生存因素分析[J].中华肿瘤防治杂志,2011,18(14):1118-1120. 被引量:9
  • 9Imamura H,Matsuyama Y,Tanaka E,et al. Risk factors contribut- ing to early and late phase intrahepatic recurrence of bepato- cellular carcinoma after hepatectomy. J Hepatol,2003,38:200- 207.
  • 10Erco|ani G,Grazi GL,Ravaioli M,et al. Liver resection for hepa- tocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg, 2003,237:536-543.

二级参考文献22

  • 1祁付珍,吴清泉,张平,郑翔翔,韩学东.肝癌根治术后早期肝内复发危险因素分析[J].中国肿瘤,2004,13(8):520-522. 被引量:4
  • 2Wakai T, Shirai Y, Yokoyama N, et al. Hepatitis vrial status affects the pattern of intrahepatic recurrence after resection {or hepatocellular earcinomal[J]. J S O, 2003, 29(3): 266 -271.
  • 3Iwamoto S, Sanefuji H, Okuda K, et al. Angiographic subseg mentectomy for the treatment of patinents with small hepatocel lular carcinoma[J]. Cancer,2003,97(4) :1051- 1056.
  • 4Wuestefeld T, Zender L. DLC1 and liver cancer: the Akt con nection[J]. Gastroenterology, 2010, 139(4):1093 -1096.
  • 5Huo TI, Lui WY, Wu JC, et al. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence[J]. World J Surg, 2004,28(3):258-262.
  • 6Cha C, Fong Y, Jarnagin WR, et al.Predictors and patterns ofrecurrence after resection of hepatocellular carcinoma[J]. J Am Coll Surg, 2003,197(5):753-758.
  • 7Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy[J]. J Hepatol, 2003,38(2): 200-207.
  • 8Huo TI, Huang YH, Lui WY, et al. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center[J]. Oncol Rep, 2004,11(2):543-550.
  • 9Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma[J]. Ann Surg, 2000,232(1):10-24.
  • 10Wang W, Yang LY, Huang GW, et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis[J]. Br J Cancer, 2004,90(12):2349-2355.

共引文献13

同被引文献47

  • 1Zheng-Gui Du,Yong-Gang Wei,Ke-Fei Chen,Bo Li.Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients[J].Hepatobiliary & Pancreatic Diseases International,2014,13(2):153-161. 被引量:21
  • 2Jong Young Choi,Seung Won Jung,Hee Yeon Kim,Myungshin Kim,Yonggoo Kim,Dong Goo Kim,Eun-Jee Oh.Diagnostic value of AFP-L3 and PIVKA-Ⅱin hepatocellular carcinoma according to total-AFP[J].World Journal of Gastroenterology,2013,19(3):339-346. 被引量:68
  • 3Panjala C,Senecal DL, Bridges MD, et al. The diagnostic conun-drum and liver transplantation outcome for combined hepatocel- lular-cholangiocarcinoma[J]. Am J Transplant, 2010, 10 ( 5 ) : 1263-1267.
  • 4Goodman ZD, lshak KG, Langloss J M, et al.Combined hepatoeel- lular-cholangiocarcinoma. A histologic and immunohistochemical study[J]. Cancer, 1985,55 (1) : 124-129.
  • 5Wachtel MS,Zhang Y,Xu T, et al. Combined hepatocellular cholangio- carcinomas;analysis of a large database[J]. Clin Med Pathol, 2008, 1 (1) :43-47.
  • 6Akiba J, Nakashima O, Hattori S, et al. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification [J]. Am J Surg Pathol, 2013,37 (4) : 496-505.
  • 7Yin X, Zhang BH, Qiu SJ, et al. Combined hepatocellular carcino- ma and cholangiocarcinoma: clinical features, treatment modali- ties,and prognosis[J].Ann Surg Oneol,2012,19(9) :2869-2876.
  • 8Kim KH, Lee SG, Park EH, et al. Surgical treatments and prog- noses of patients with combined hepatocellular carcinoma and cholangiocarcinoma[J]. Ann Surg Oncol, 2009,16 (3): 623-629.
  • 9Wang J,Wang F, Kessinger A. Outcome of combined hepatocel- lular and cholangiocareinoma of the liver [J]. J Oncol, 2010, 2010:917356.
  • 10Sapisochin G, Fidelman N, Roberts JP, et al. Mixed hepatoeellu- lar cholangiocareinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatoeellular carcinoma [J]. Liver Transpl,2011,17(8)..934-942.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部